Auricular Peripheral Nerve Stimulation for Withdrawal and Pain Relief
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for opioid withdrawal and chronic pain, such as pharmacological methods, have limitations including adverse side effects, unpredictable efficacy, and the risk of precipitated withdrawal, while functional abdominal pain disorders lack effective management options.
Innovation Solution
A method involving electrical nerve field stimulation, specifically targeting cranial nerves in the auricular and peri-auricular areas using a stimulator device to deliver electrical signals, which can be administered prophylactically or post-symptom onset, optionally combined with secondary drugs.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If pharmacological methods are used to treat opioid withdrawal, then withdrawal symptoms can be managed, but adverse side effects and risk of precipitated withdrawal occur
Solution Approach 1:
The patent replaces pharmacological treatment (chemical system) with electrical nerve field stimulation (physical/electrical system). The stimulator device delivers electrical signals to peripheral nerves to modulate neural activity and reduce withdrawal symptoms, thereby avoiding the adverse side effects and precipitated withdrawal risk associated with pharmacological methods while maintaining treatment effectiveness.
2Reliability
If traditional pain medications are used, then pain relief is achieved, but adverse side effects and unpredictable efficacy occur
Solution Approach 1:
The patent replaces traditional pharmacological pain management with electrical nerve field stimulation. The stimulator device provides controlled electrical signals to peripheral nerves, offering predictable and adjustable pain relief without the adverse side effects associated with traditional pain medications. The electrical stimulation modulates pain transmission pathways directly, providing reliable analgesia.
3Reliability
If pharmacotherapy is used for opioid detox, then withdrawal symptoms are treated, but treatment compliance decreases due to unpredictable efficacy
Solution Approach 1:
The patent replaces pharmacotherapy with electrical nerve field stimulation, providing a non-pharmacological approach that offers predictable and controllable results. The stimulator device allows for adjustable stimulation parameters and can be used on-demand, giving patients greater control over their treatment and improving compliance. The electrical stimulation directly targets the neural mechanisms of withdrawal without the variability associated with medication response.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach effectively reduces withdrawal symptoms and pain by altering neural activity, providing rapid relief and minimizing side effects, with potential for improved treatment compliance and reduced reliance on traditional medications.
Implementation Method 1
A method involving electrical nerve field stimulation, specifically targeting cranial nerves in the auricular and peri-auricular areas using a stimulator device to deliver electrical signals
Data Source
AI summary
A method for treating pain or discomfort in a patient is disclosed. The method comprises stimulating a cranial nerve with an electrical signal. The pain or discomfort may be a withdrawal symptom. The cranial nerve may be in an auricular area of the patient. The cranial nerve may be cranial nerve V, cranial nerve VII, cranial nerve IX, cranial nerve X, or branches of greater and lesser occipital nerves thereof and their associated neurovascular bundles. The withdrawal symptom may result from cessation of an opioid. The method may further comprise administering a secondary drug treats one or more of the withdrawal symptoms and addiction. The secondary drug may be administered about one day to about one week after initiating the stimulating step.